z-logo
open-access-imgOpen Access
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Author(s) -
Roxana Mehran,
Philippe Gabríel Steg,
Marc A. Pfeffer,
Karola Jering,
Brian Claggett,
Eldrin F. Lewis,
Christopher B. Granger,
Lars Køber,
Aldo P. Maggioni,
Douglas L. Mann,
John J.V. McMurray,
JeanLucien Rouleau,
Scott D. Solomon,
Grégory Ducrocq,
Otávio Berwanger,
Carmine G. De Pasquale,
Ulf Landmesser,
Mark C. Petrie,
David Sim Kheng Leng,
Peter van der Meer,
Martin Lefkowitz,
Yig Zhou,
Eugene Braunwald
Publication year - 2022
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.122.060841
Subject(s) - medicine , myocardial infarction , cardiology , valsartan , heart failure , ramipril , hazard ratio , unstable angina , blood pressure , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom